Biomerieux – Group report and key figures
A report presented through summary slides of group's operations
Detailed history of financial performances between 2023 and 2024
An overview of the group's major business strategies
A medium-term outlook for opportunities and threats
650 €
WHAT IS THE GROUPS' FINANCIAL SITUATION ?
The financial indicators presented in this report include: consolidated revenue, consolidated EBIT and EBIT ratio, consolidated net profit and net profit rate, R&D expenditure and ratio, sales by segment and by region, profitability, liquidity and solvency ratios, free cash flow and capital expenditure.
WHAT ARE THE GROUP'S STRATEGIC PRIORITIES ?
Extend leadership positions in key markets through external growth
Sustain expansive innovation footprint and investment
Enhance service integration to develop a comprehensive offering
WHAT ARE THE GROUP'S STRENGTHS AND WEAKNESSES ?
Through a SWOT analysis, this report also provides an overview of the group's strengths (solid financial position facilitates investments to grow production footprint and engage in M&A activities, etc.) and weaknesses (smaller in size compared to major European and American rivals, etc.).
Exploit the entire Xerfi content library (1,000 studies, 10,000 videos, and hundreds of articles) to produce market research, competitive intelligence, and strategic insights using simple prompts.
Detailed plan
Presentation
Segments
SWOT
ACCESS THE REPORT
